Tag: Arexvy
GSK’s Arexvy label expansion will intensify competition with Pfizer’s Abrysvo in...
The European Medicines Agency (EMA) recently accepted the company’s regulatory application to expand the use of Arexvy and a decision is anticipated in H2 2024